ORM-1153

N/A

Report date: 2026/05/07 10:15:27

Base Information

Drug NameORM-1153

Drug Alias NameORM-1153

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugate > Antibody degrader conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > SMol006 payloadBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Cleavable linker > β-glucuronide linker

Mechanisms of ActionAnti-CD123Eukaryotic peptide chain release factor GTP-binding subunit ERF3A degraders

TargetsInterleukin-3 receptor subunit alphaEukaryotic peptide chain release factor GTP-binding subunit ERF3A

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesOrum Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesOrum Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsN/A

Other Information

ATC CodeN/A